Rankings
▼
Calendar
VIR Q1 2024 Earnings — Vir Biotechnology, Inc. Revenue & Financial Results | Market Cap Arena
VIR
Vir Biotechnology, Inc.
$1B
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$56M
-10.5% YoY
Gross Profit
-$42M
-74.8% margin
Operating Income
-$80M
-142.0% margin
Net Income
-$65M
-115.8% margin
EPS (Diluted)
$-0.48
QoQ Revenue Growth
+235.8%
Cash Flow
Operating Cash Flow
-$109M
Free Cash Flow
-$111M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$247M
Stockholders' Equity
$1.5B
Cash & Equivalents
$161M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$56M
$63M
-10.5%
Gross Profit
-$42M
-$97M
+56.4%
Operating Income
-$80M
-$143M
+44.1%
Net Income
-$65M
-$141M
+53.7%
Revenue Segments
Contract Revenue
$52M
91%
Grant
$5M
9%
← FY 2024
All Quarters
Q2 2024 →